How does Exact Sciences Corp. (EXAS) change from a tortoise to a hare?

With 3.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.02 million shares. The 52-week range on EXAS shows that it touched its highest point at $100.77 and its lowest point at $56.05 during that stretch. It currently has a 1-year price target of $89.78. Beta for the stock currently stands at 1.25.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EXAS was up-trending over the past week, with a rise of 13.38%, but this was up by 22.39% over a month. Three-month performance dropped to -7.01% while six-month performance rose 1.81%. The stock gained 4.92% in the past year, while it has lost -4.83% so far this year. A look at the trailing 12-month EPS for EXAS yields -1.14 with Next year EPS estimates of 0.12. For the next quarter, that number is -0.48. This implies an EPS growth rate of 21.81% for this year and 114.05% for next year.

Float and Shares Shorts:

At present, 181.36 million EXAS shares are outstanding with a float of 179.64 million shares on hand for trading. On Mar 15, 2024, short shares totaled 6.52 million, which was 3.59% higher than short shares on Feb 15, 2024. In addition to EXAS as the firm’s Exact Sciences Corporation, EXAI serves as its Exscientia Plc.

Institutional Ownership:

Through their ownership of 89.48% of EXAS’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EXAS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, EXAS has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and EXAS currently yields $0.00. In the past year, EXAS’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, EXAS has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.